Temporal and structural patterns of extended-spectrum cephalosporin-resistant Klebsiella pneumoniae incidence in Swiss hospitals

Journal of Hospital Infection - Tập 120 - Trang 36-42 - 2022
L. Renggli1, M. Gasser1, C. Plüss-Suard1, S. Harbarth2, A. Kronenberg1
1Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern, Bern, Switzerland
2Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, WHO Collaborating Centre, Geneva, Switzerland

Tài liệu tham khảo

Tacconelli, 2018, Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis, Lancet Infect Dis, 18, 318, 10.1016/S1473-3099(17)30753-3 Cassini, 2019, Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis, Lancet Infect Dis, 19, 56, 10.1016/S1473-3099(18)30605-4 Gasser, 2019, Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland, Lancet Infect Dis, 19, 17, 10.1016/S1473-3099(18)30708-4 2012 2020 2015 2020 Rice, 1996, Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center, Clin Infect Dis, 23, 118, 10.1093/clinids/23.1.118 Asensio, 2000, Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection, Clin Infect Dis, 30, 55, 10.1086/313590 Du, 2002, Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome, Intensive Care Med, 28, 1718, 10.1007/s00134-002-1521-1 Lee, 2004, Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Infect Control Hosp Epidemiol, 25, 832, 10.1086/502304 Deng, 2017, Risk factors and molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Xiamen, China, J Glob Antimicrob Resist, 11, 23, 10.1016/j.jgar.2017.04.015 Pessoa-Silva, 2003, Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization, J Hosp Infect, 53, 198, 10.1053/jhin.2002.1373 Lautenbach, 2001, Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes, Clin Infect Dis, 32, 1162, 10.1086/319757 Abayneh, 2018, Isolation of extended-spectrum beta-lactamase- (ESBL-) producing Escherichia coli and Klebsiella pneumoniae from patients with community-onset urinary tract infections in Jimma University Specialized Hospital, Southwest Ethiopia, Can J Infect Dis Med Microbiol, 2018, 4846159, 10.1155/2018/4846159 Tissot, 2014 2021 2020 Woerther, 2017, Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level, J Travel Med, 24, S29, 10.1093/jtm/taw101 Nellums, 2018, Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis, Lancet Infect Dis, 18, 796, 10.1016/S1473-3099(18)30219-6 MacFadden, 2018, Antibiotic resistance increases with local temperature, Nat Clim Chang, 8, 510, 10.1038/s41558-018-0161-6 Riccio, 2021, Household acquisition and transmission of extended-spectrum β-lactamase (ESBL)-producing Entero-bacteriaceae after hospital discharge of ESBL-positive index patients, Clin Microbiol Infect, 27, 1322, 10.1016/j.cmi.2020.12.024 Kachalov, 2021, Identifying the drivers of multidrug-resistant Klebsiella pneumoniae at a European level, PLoS Comput Biol, 17, 10.1371/journal.pcbi.1008446 Hilty, 2012, Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting, Clin Infect Dis, 55, 967, 10.1093/cid/cis581 Zingg, 2019, National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland. 2017, Euro Surveill, 24 Kuster, 2008, Correlation between case mix index and antibiotic use in hospitals, J Antimicrob Chemother, 62, 837, 10.1093/jac/dkn275 Cusini, 2018, Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in Escherichia coli and Klebsiella pneumoniae: a retrospective observational study, Antimicrob Resist Infect Control, 7, 89, 10.1186/s13756-018-0387-0 Wiener, 1999, Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes, JAMA, 281, 517, 10.1001/jama.281.6.517 Quan, 2017, High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China, J Antimicrob Chemother, 72, 273, 10.1093/jac/dkw372 2021 2021 Klein, 2021, Assessment of WHO antibiotic consumption and access targets in 76 countries. 2000–15: an analysis of pharmaceutical sales data, Lancet Infect Dis, 21, 107, 10.1016/S1473-3099(20)30332-7 2020 Harbarth, 2001, Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in Gram-negative bacilli, Clin Infect Dis, 33, 1462, 10.1086/322677 Pasricha, 2013, Carriage of extended-spectrum beta-lactamase-producing Enterobacteriacae among internal medicine patients in Switzerland, Antimicrob Resist Infect Control, 2, 20, 10.1186/2047-2994-2-20 Maechler, 2020, Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial, Lancet Infect Dis, 20, 575, 10.1016/S1473-3099(19)30626-7 Martischang, 2019, Nation-wide survey of screening practices to detect carriers of multi-drug resistant organisms upon admission to Swiss healthcare institutions, Antimicrob Resist Infect Control, 8, 37, 10.1186/s13756-019-0479-5